Lilly and Insilico Enter $2.75B AI Drug Discovery Deal
Lilly expands AI drug discovery push with Insilico collaboration worth up to $2.75B Insilico Medicine has announced a drug discovery
Read moreLilly expands AI drug discovery push with Insilico collaboration worth up to $2.75B Insilico Medicine has announced a drug discovery
Read moreSanofi has announced it has agreed to acquire Dynavax Technologies Corporation, a publicly traded vaccines company, in a move that
Read moreEli Lilly and Company (NYSE: LLY) announced a groundbreaking collaboration with NVIDIA to build the most powerful supercomputer ever owned
Read morePfizer Inc. has reached a sweeping agreement with the Trump Administration that will reduce prescription drug costs for U.S. patients
Read moreThe definitive merger agreement, valued at up to $3.5 billion, grants Roche control of the late-stage FGF21 analog, pegozafermin, for
Read moreCantargia AB has announced a landmark agreement with Japanese pharma giant Otsuka Pharmaceutical Co., Ltd., granting Otsuka exclusive global rights
Read moreSanofi has announced a definitive agreement to acquire Blueprint Medicines, a U.S.-based biopharmaceutical company focused on systemic mastocytosis (SM) and
Read moreSanofi has announced a definitive agreement to acquire clinical-stage biotech firm Vigil Neuroscience, Inc., in a move to expand its
Read moreBioMarin Pharmaceutical Inc. has entered into a definitive agreement to acquire clinical-stage biotech Inozyme Pharma, Inc. for approximately $270 million
Read moreIn a strategic move to expand its oncology pipeline, GSK plc (LSE/NYSE: GSK) announced on Tuesday, it has entered into
Read more